Rockland Trust’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
2,956
-1,287
-30% -$393K 0.04% 142
2026
Q1
$1.06M Sell
4,243
-1,920
-31% -$478K 0.04% 141
2025
Q4
$1.7M Sell
6,163
-76,903
-93% -$21M 0.07% 116
2025
Q3
$21.8M Buy
83,066
+5,087
+7% +$1.24M 0.89% 37
2025
Q2
$17.1M Buy
77,979
+13,255
+20% +$2.83M 0.83% 40
2025
Q1
$14.5M Buy
64,724
+4,980
+8% +$1.37M 0.73% 44
2024
Q4
$19.6M Buy
59,744
+3,102
+5% +$976K 1% 34
2024
Q3
$17M Buy
56,642
+3,055
+6% +$936K 0.84% 41
2024
Q2
$17.7M Buy
53,587
+1,153
+2% +$407K 0.93% 35
2024
Q1
$20.7M Buy
52,434
+400
+0.8% +$148K 1.09% 32
2023
Q4
$18.3M Buy
52,034
+243
+0.5% +$86K 1% 35
2023
Q3
$19.4M Sell
51,791
-574
-1% -$222K 1.17% 27
2023
Q2
$20M Sell
52,365
-1,021
-2% -$365K 1.2% 25
2023
Q1
$18.5M Buy
53,386
+7,316
+16% +$2.14M 1.16% 25
2022
Q4
$10.8M Sell
46,070
-3,780
-8% -$896K 0.69% 51
2022
Q3
$12.3M Buy
49,850
+1,446
+3% +$441K 0.88% 43
2022
Q2
$14.6M Buy
48,404
+47,130
+3,699% +$15.3M 1.01% 32
2022
Q1
$523K Buy
1,274
+26
+2% +$10.2K 0.03% 202
2021
Q4
$585K Sell
1,248
-245
-16% -$105K 0.04% 196
2021
Q3
$634K Hold
1,493
0.04% 181
2021
Q2
$536K Buy
+1,493
New +$493K 0.04% 193

Other funds holding WST